These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18502123)

  • 1. Development of potent and selective small-molecule human Urotensin-II antagonists.
    McAtee JJ; Dodson JW; Dowdell SE; Girard GR; Goodman KB; Hilfiker MA; Sehon CA; Sha D; Wang GZ; Wang N; Viet AQ; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Yuan CC; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3500-3. PubMed ID: 18502123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles.
    McAtee JJ; Dodson JW; Dowdell SE; Erhard K; Girard GR; Goodman KB; Hilfiker MA; Jin J; Sehon CA; Sha D; Shi D; Wang F; Wang GZ; Wang N; Wang Y; Viet AQ; Yuan CC; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3716-9. PubMed ID: 18524591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis.
    Shirai J; Yamaoka M; Imamiya E; Nakamura M; Tarui N; Hashimoto T; Ikeura Y
    Bioorg Med Chem; 2011 Sep; 19(17):5175-82. PubMed ID: 21807525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonists.
    Jin J; Dhanak D; Knight SD; Widdowson K; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Schmidt DB; Bennett CD; Wang B; Warren GL; Moore ML; Keenan RM; Rivero RA; Douglas SA
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3229-32. PubMed ID: 15936190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.
    Lum RT; Cheng M; Cristobal CP; Goldfine ID; Evans JL; Keck JG; Macsata RW; Manchem VP; Matsumoto Y; Park SJ; Rao SS; Robinson L; Shi S; Spevak WR; Schow SR
    J Med Chem; 2008 Oct; 51(19):6173-87. PubMed ID: 18788731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).
    Masood MA; Selby MD; Bell AS; Mansfield AC; Gardner M; Smith GF; Lane C; Kenyon-Edwards H; Osborne R; Jones RM; Liu WL; Brown CD; Clarke N; Perrucio F; Mowbray CE
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6591-5. PubMed ID: 21955944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
    Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent and selective small molecule hGPR91 antagonist.
    Bhuniya D; Umrani D; Dave B; Salunke D; Kukreja G; Gundu J; Naykodi M; Shaikh NS; Shitole P; Kurhade S; De S; Majumdar S; Reddy SB; Tambe S; Shejul Y; Chugh A; Palle VP; Mookhtiar KA; Cully D; Vacca J; Chakravarty PK; Nargund RP; Wright SD; Graziano MP; Singh SB; Roy S; Cai TQ
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3596-602. PubMed ID: 21571530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel small molecule bradykinin B2 receptor antagonists.
    Gibson C; Schnatbaum K; Pfeifer JR; Locardi E; Paschke M; Reimer U; Richter U; Scharn D; Faussner A; Tradler T
    J Med Chem; 2009 Jul; 52(14):4370-9. PubMed ID: 19552431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability.
    Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Tomishima Y; Toda Y; Saito S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6299-304. PubMed ID: 17884496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isochromanone-based urotensin-II receptor agonists.
    Lehmann F; Currier EA; Olsson R; Hacksell U; Luthman K
    Bioorg Med Chem; 2005 Apr; 13(8):3057-68. PubMed ID: 15781415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H; Xin Z; Patel JR; Nelson LT; Liu B; Szczepankiewicz BG; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1825-8. PubMed ID: 15780615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Aminomethyl piperidines as novel urotensin-II receptor antagonists.
    Jin J; Wang Y; Wang F; Shi D; Erhard KF; Wu Z; Guida BF; Lawrence SK; Behm DJ; Disa J; Vaidya KS; Evans C; McMillan LJ; Rivero RA; Neeb MJ; Douglas SA
    Bioorg Med Chem Lett; 2008 May; 18(9):2860-4. PubMed ID: 18420409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)-5-{2-[3-(substituted)-1-azetidinyl]-ethyl}-2-piperidones. Part 2: Improving oral absorption.
    Middleton DS; MacKenzie AR; Newman SD; Corless M; Warren A; Marchington AP; Jones B
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3957-61. PubMed ID: 16039119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists.
    Stasi LP; Artusi R; Bovino C; Buzzi B; Canciani L; Caselli G; Colace F; Garofalo P; Giambuzzi S; Larger P; Letari O; Mandelli S; Perugini L; Pucci S; Salvi M; Toro P
    Bioorg Med Chem Lett; 2013 May; 23(9):2653-8. PubMed ID: 23535328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic properties.
    Wendt JA; Wu H; Stenmark HG; Boys ML; Downs VL; Penning TD; Chen BB; Wang Y; Duffin T; Finn MB; Keene JL; Engleman VW; Freeman SK; Hanneke ML; Shannon KE; Nickols MA; Steininger CN; Westlin M; Klover JA; Westlin W; Nickols GA; Russell MA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):845-9. PubMed ID: 16303301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.
    Du Y; Li Q; Xiong B; Hui X; Wang X; Feng Y; Meng T; Hu D; Zhang D; Wang M; Shen J
    Bioorg Med Chem; 2010 Jun; 18(12):4255-68. PubMed ID: 20510622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.